Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

DeCODE partners sequence-based clinical diagnostics IP with start-up NextCODE

Executive Summary

Start-up NextCODE Health LLC received exclusive rights over the next five years to Icelandic life sciences company deCODE genetics EHF’s genomics platform, which will allow NextCODE to develop sequence-based clinical diagnostics. The deal is concurrent with deCODE’s spin off of NextCODE, which also received $15mm in Series A financing from Polaris Partners and Arch Venture Partners, and will be led by former deCODE key executives.

Deal Industry
  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
  • Services
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Biotechnology
    • Drug Discovery Technologies
      • Bioinformatics
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies